GlassScriptPhysician profile
Henry L Dewitt
NPI 1619937109
$756.49
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $27.67 · 2022: $112 · 2023: $280 · 2024: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $128.82 | 2019-2024 | |
| Lilly USA, LLC | $124.07 | 2020-2024 | Mounjaro, Trulicity |
| Exact Sciences Corporation | $84.08 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $78.39 | 2019-2024 | Breztri, Farxiga |
| Novo Nordisk INC | $67.27 | 2023-2024 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $60.50 | 2019-2024 | Shingrix |
| E.R. Squibb & Sons, L.L.C. | $37.97 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.22 | 2023 | Xifaxan |
| Dexcom, INC. | $22.88 | 2024 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $21.43 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.24 | 2024 | Jardiance |
| Genentech USA, INC. | $16.58 | 2022 | |
| Medtronic Vascular, INC. | $15.26 | 2019 | |
| Amarin Pharma, INC. | $14.75 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.43 | 2024 | Opsumit, Uptravi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.81 | 2024 | |
| Sanofi Pasteur INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Dewitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.